NeuroSense
presentation
ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that leads to paralysis and ultimately death. NeuroSense is spearheading a new approach for treating ALS. We aim to halt, or significantly delay disease progression by creating a new unique formulation that have been found to demonstrate an outstanding effect in an ALS model.
